Meeting On Public and Private Markets and Policy Surveys

Friday 18 September 2009

Venue: DNDi

15 Chemin Louis-Dunant

1202 GENEVA

Tel : + 41 (0)22 906 92 30

Meeting objective: Sharing of results from Burundi & Sierra Leone surveys and listening to key malaria stakeholders for improving use of ACTs in public and private markets

Reporters: Karly Louie/Ann-Marie Sevcsik

09:00-9:10Opening by Bernard Pecoul, Chair of the meeting

Morning Session: Co-Chaired by Olusoji Adeyi (AMFm)

09:10-10:45 Presentation of Rational, Methodology and Results of Burundi & Sierra Leone Surveys: Graciela Diap & John Amuasi

Questions for clarification

10:45-11:00 Taking ASAQ as example, how WHO policies could reinforce ACTs implementation in Africa? Peter Olumese

11:00-11:30 Based on outcomes of Burundi &SL surveys, what is recommended to optimise ACTs distribution at community level and through private sector channels in Africa? Prudence Hamade (Malaria Consortium) and Franco Pagnoni (TDR)

11:30-11:45Coffee break

11:45-12:45 Comments by Richard Laing (WHO), Patrick Mubangizi (HAI), Martin De Smet (MSF), PaulLibiszowski (MACEPA),Clive Ondari (WHO) and Tanya Shewchuk (ACT Watch-PSI)

12:45-13:00 Plenary discussion

13:00-14:00Lunch

Afternoon Session: Co-Chaired by Angus Spiers(UNICEF)

14:00-14:15 Current state of and forecast for ASAQ market

René Cazetien (s-a)

14:15-14:45 Interim results of the MoH-MMV ACT subsidy pilot in Uganda

Penny Grewal Daumerie

14:45-15:30 Key issues to improve rational use of ACTs based on empirical examples (ASAQ and Coartem®) presented during the meeting

Kathleen L. Strong(UNITAID), Jan van Erps (RBM), Melisse Murray (GF) and Jean-Marie Kindermans (MSF)

15:30-15:45 Plenary discussion

15:45-16:00Coffee break

16:00- 16:45 Plenary discussion (outcome expected: consensus on what was said to move it forward) chaired by B Pecoul

16:45-17:00 Closing remarks by B Pecoul/ End of meeting

Papers in attendee’s folder:

Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, et al. 2009Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug Shops in Rural Tanzania. PLoS ONE 4(9):e6857

Goodman C, Kachur P, Abdulla S, Bloland P and Mills A. Concentration and drug prices in the retail market for malaria in rural Tanzania. Health Econ. 18: 727–742 (2009)

Pecoul B, Sevcsik A, Amuasi J, Diap G, Kiechel J: The story of ASAQ: the first antimalarial product development partnership success. Health Partnerships Review 2008

Navaratnam V, Ramanathan S, Wahab MS, Siew Hua G, Mansor SM, Kiechel JR, Vaillant M, Taylor WR, Olliaro P. Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers. Eur J Clin Pharmacol. 2009 Aug; 65(8):809-21

Fitoussi S, Thang C, Lesauvage E, Barré J, Charron B, Filali-Ansary A and Lameyre V. Bioavailability of a Co-formulated Combination of Amodiaquine and Artesunate under Fed and fasted Conditions. Arzneiittelforschung 2009;59(7):370-376

Sirima S, Tiono A, Gansané A, Diarra A, Ouédraogo A, Konaté A, Kiechel JR, Morgan C, Olliaro P and Taylor W. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J 2009, 8:48

Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Niawanlou Dara YD, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O. Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J 2009, 8:125

Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima S, van den Broek I, Yeka A, Taylor W, Dorsey G and Randrianarivelojosia M. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J 2009, 8:203

List of Participants

NMCP:

  1. Lievin Nsabiyumva(Burundi)
  2. Jambai Amara (Sierra Leone)

WHO:

  1. Peter Olumese (GMP)
  2. Richard Laing
  3. Franco Pagnoni (TDR)
  4. Clive Ondari (EML)

UNICEF:

  1. Angus Spiers

MSF:

  1. Selina Lo (Access Campaign)
  2. Martin DE SMET
  3. Jean-Marie KINDERMANS

HAI:

  1. Patrick Mubangizi

PSI:

  1. Tanya Shewchuk

GF:

  1. Melisse Murray
  2. Olusoji Adeyi (AMFm)

UNITAID:

  1. Kathleen L. Strong

RBM:

  1. Jan Van Erps
  2. Paul Libiszowki (MACEPA)

CHAI:

  1. Ellen Chang

MMV:

  1. Penny Grewal Daumerie
  2. Susan Boboulsky (Stanford Business School)

Malaria Consortium:

  1. Prudence Hamade

s-a:

  1. François Bompart
  2. René Cazetien

DNDi

  1. Bernard Pecoul
  2. Nathalie Strub-Wourgaft
  3. Jean René Kiechel
  4. Florence Camus Bablon
  5. Gwenaelle Carn
  6. Ralph de Coulom
  7. Ann-Marie –Karly Louis
  8. John Amuasi
  9. Graciela Diap

1